Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear
- 8 May 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (21), 11781-11787
- https://doi.org/10.1073/pnas.1920147117
Abstract
Benzodiazepines (BZDs) represent the gold standard of anxiolytic pharmacotherapy; however, their clinical benefit is limited by side effects and addictive potential. Consequently, there is an urgent need to develop novel and safe anxiolytics. The peptide hormone oxytocin (OXT) exhibits anxiolytic-like properties in animals and humans, but whether OXT and BZDs share similar effects on the neural circuitry of fear is unclear. Therefore, the rationale of this ultra-high-field functional MRI (fMRI) study was to test OXT against the clinical comparator lorazepam (LZP) with regard to their neuromodulatory effects on local and network responses to fear-related stimuli. One hundred twenty-eight healthy male participants volunteered in this randomized double-blind, placebo-controlled, between-group study. Before scanning using an emotional face-matching paradigm, participants were randomly administered a single dose of OXT (24 IU), LZP (1 mg), or placebo. On the behavioral level, LZP, but not OXT, caused mild sedation, as evidenced by a 19% increase in reaction times. On the neural level, both OXT and LZP inhibited responses to fearful faces vs. neutral faces within the centromedial amygdala (cmA). In contrast, they had different effects on intra-amygdalar connectivity; OXT strengthened the coupling between the cmA and basolateral amygdala, whereas LZP increased the interplay between the cmA and superficial amygdala. Furthermore, OXT, but not LZP, enhanced the coupling between the cmA and the precuneus and dorsomedial prefrontal cortex. These data implicate inhibition of the cmA as a common denominator of anxiolytic action, with only OXT inducing large-scale connectivity changes of potential therapeutic relevance.Keywords
This publication has 70 references indexed in Scilit:
- High-resolution functional MRI of the human amygdala at 7TEuropean Journal of Radiology, 2013
- Amygdala circuitry mediating reversible and bidirectional control of anxietyNature, 2011
- Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety DisorderNeuropsychopharmacology, 2010
- Three dimensional echo-planar imaging at 7 TeslaNeuroImage, 2010
- Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humansProceedings of the National Academy of Sciences of the United States of America, 2010
- Medial Prefrontal Cortex 5-HT2A Density Is Correlated with Amygdala Reactivity, Response Habituation, and Functional CouplingCerebral Cortex, 2009
- Individual Differences in Typical Reappraisal Use Predict Amygdala and Prefrontal ResponsesBiological Psychiatry, 2009
- Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific PhobiaAmerican Journal of Psychiatry, 2007
- Evolution of the amygdaloid complex in vertebrates, with special reference to the anamnio‐amniotic transitionJournal of Anatomy, 2007
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005